A comparison of different methods for diagnosing acromegaly

Clinical Endocrinology

Volumn 46, Issue 5, 1997, Pages 531-537

  Stoffel Wagner, B ^a,b   Springer, W ^a   Bidlingmaier, F ^a   Klingmuller D ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Institut fur Klinische Biochemie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HORMONE BLOOD LEVEL; HORMONE URINE LEVEL; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL;

EID: 0030800103     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.1430983.x     Document Type: Article

References (18)

1. Barkan, A.L. (1988) Acromegaly: diagnosis and therapy. Endocrinology and Metabolism Clinics of North America, 18, 227-310.
2. Baumann, G. (1991) Growth hormone heterogenity: genes, isohormones, variants and binding proteins, Endocrine Reviews, 12, 424-449.
3. Cohen, P., Fielder, P.J., Hasegawa, Y., Fritsch, H., Giudice, L.C. & Rosenfeld, R.G. (1991) Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinologica (Copenhagen), 124, 74-85.
4. Daughaday, W.H. & Rotwein, P. (1989) Insulin-like growth factors I and II: peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocrine Reviews, 10, 68-90.
5. Earll, J.M., Sparks. L.L. & Forsham, P.H. (1967) Glucose suppression of serum growth hormone in the diagnosis of acromegaly. Journal of the American Medical Association, 201, 134-136.
6. Grinspoon, S., Clemmons, D., Swearingen, B. & Klibanski, A. (1995) Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly. Journal of Clinical Endocrinology and Metabolism, 80, 927-932.
7. Hasegawa, Y., Cohen, P., Yorgin, P. & Rosenfeld, R.G. (1992) Characterization of urinary insulin-like growth factor binding proteins. Journal of Clinical Endocrinology and Metabolism, 74, 830-835.
8. Hattori, N., Shimatsu, A., Kato, Y., Koshiyama, H., Ishikawa, Y., Assadian, H., Tanoh, T., Nagao, M. & Imura, H. (1990) Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly. Journal of Clinical Endocrinology and Metabolism, 70, 771-776.
9. Juul, A., Main, K., Blum, W.F., Lindholm, J., Ranke, M.B. & Skakkebaek, N.E. (1994) The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clinical Endocrinology (Oxford), 41, 85-93.
10. Levitt, N.S., Ratanjee, B.D. & Abrahamson, M.J. (1995) Do "so-called" normal growth hormone concentrations (2-5 μg/l) indicate cure in acromegaly? Hormone and Metabolic Research, 27, 185-188.
11. Lindholm, J., Giwercman, B., Giwercman, A., Astrup, J., Bjerre, P. & Skakkebaek, N.E. (1987) Investigation of the criteria for assessing the outcome of treatment in acromegaly. Clinical Endocrinology (Oxford), 27, 553-562.
12. Lunt, H., Tucker, A.J., Bullen, H., Gibbs, C. & Wilkin, T.J. (1990) Overnight urinary growth hormone measurement in the diagnosis of acromegaly. Clinical Endocrinology (Oxford), 33, 205-212.
13. Pholsena, M., Le Bouc, Y., Rousseau, E., Christol, R., Birman, P., Perin, L. & Girard, F. (1993) Evaluation of acromegaly by measurement of 24-hourly urinary growth hormone excretion. Acta Endocrinologica (Copenhagen), 128, 9-14.
14. Rieu, M., Girard, F., Bricaire, H. & Binoux, M. (1982) The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly. Journal of Clinical Endocrinology and Metabolism, 55, 147-153.
15. Smith, W.J., Underwood, L.E. & Clemmons, D.R. (1995) Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. Journal of Clinical Endocrinology and Metabolism, 80, 443-449.
16. Stonesifer, L.D., Jordan, R.M. & Kohler, P.O. (1981) Somatomedin C in treated acromegaly: poor correlation with growth hormone and clinical response. Journal of Clinical Endocrinology and Metabolism, 53, 931-934.
17. Weissberger, A.J., Ho, K.Y. & Stuart, M.C. (1989) Quantification of urinary growth hormone (GH) excretion by centrifugal ultrafiltration and radioimmunoassay: appraisal of the relationship between 24 h urinary GH and mean 24 h serum GH levels in normal and abnormal states of GH secretion. Clinical Endocrinology (Oxford), 30, 687-698.
18. Winer, L.M., Shaw, M.A. & Baumann, G. (1989) Urinary growth hormone excretion rates in normal and acromegalic man: a critical appraisal of its potential clinical utility. Journal of Endocrinological Investigation, 12, 461-467.